New Nicotine Alliance Sweden (NNA Sweden) is a brand new Swedish Tobacco Harm Reduction promoting civil society, started early in 2017. NNA Sweden is an affiliate of NNA UK and NNA AU, as well as a member organisation of the global network of consumer advocacy organisations for safer nicotine products, INNCO.org.
The public launch of NNA Sweden took place at the Swedish premiere of A Billion Lives on February 7th. The premiere sported Aaron Biebert, snus advocacy crowds, vaping advocacy crowds, politicians, health economists and decision makers from the Swedish tobacco control landscape. The initial board of trustees for NNA Sweden are Atakan Erik Befrits from policy research, Ms Jennie Gejel a veteran vaping expert and Mr Patrick Pihl who is a 25 year veteran of snus advocacy and covers snus science in Sweden.
NNA Sweden aims to give a valuable contribution to both Swedish tobacco control policy work and to the important international work being done to safeguard rights to harm reduction products and policy.
Please feel free to contact us at any time to discuss cooperative efforts, access to Swedish data and experience or just to say hello.
One of the outstanding weaknesses in some recent research into e-cigarette use is the obvious lack of knowledge that some researchers and commentators have about the workings of vaping devices. indeed, whether by accident or design, some massive 'bloopers' have been made and those have had serious repercussions. How many smokers have disregarded alternative advice and have continued to smoke?
It is difficult for people who are in the front line: people who vape, to express their thoughts and counter the 'wittering's' of some experts. It is difficult for shopkeepers, hairdressers and used car salesmen to have their voices heard above the 'babble' of health professionals, politicians and media presenters all proclaiming loudly, this, that and the other.
Yet... Who are the experts when it comes to vaping? More importantly, are they really experts? Let us take a quick tour and have a look at what some 'experts' have said about vaping.
Let me start with what is to my mind, one of the 'daftest' ones. E-cigarettes may cause tuberculosis. That is correct, e-cigarettes may cause tuberculosis. The following comment appeared in the Cape Bretton Post of 2nd January 2014. It was written by an 'expert.' (But not a medical expert)
“Now most of the e-cigarettes sold here are made in China, where there is very weak government regulation with respect to how they are made. The Canadian government does not know if Chinese workers making cigarettes wear masks. If they aren’t wearing masks, there are increased risks associated with tuberculosis.”
I spotted this at the time and wrote to the professor, pointing out that...
"This is just about one of the most ridiculous statements have ever come across. Pure, unsubstantiated scaremongering and an indication of the lack of care you have taken with your research.
There is a beautiful irony here. Some ‘idiot’ has reasoned that if there is tuberculosis in China, there must be a risk involved. You have decided to parrot this. And here is the irony! You see, the main ingredient in e juice is propylene glycol. Propylene glycol is a disinfectant. And, do you know what? It is used extensively in the war against… yes… come on now… Think! That’s it… Tuberculosis!"
Yes, I know, just because propylene glycol is a constituent in e-liquid does not mean it would prevent infection via vaping - but there again, there are, as far as I am aware, no cases of tuberculosis having been caused through vaping.
Anyway, I am not an expert. Oh! And you may have noticed that my propensity for using emotive terminology has not changed between my writing back then and now - I offer no apology even though scientists avoid doing this... or do they?
An emotive headline but did the researcher claim this? It would appear he did. “[Level of PAHs] in e-cigarettes is at least one million times more than roadside air in Hong Kong,” said Dr Chung Shan-shan, assistant professor in the university’s biology department." The study itself turned out to be 'pure garbage,' sorry, I must stop doing that. The study itself contained one or two weaknesses. No, back to my own style: It was not worth the paper it was written on, or perhaps I should say, the papers it was written in, because I am not sure if the research was ever published except in the world press.
It is not a one off... The New England Journal of Medicine [Published by Marvel Comics? I can say this because I am not an expert and have no ambition to have anything published in publications of disrepute] The New England Journal of Medicine published a report that started a media frenzy.
However, is was soon revealed that, once again there were major flaws.
"This experiment, published in the New England Journal of Medicine, operated the vaping device at a such a high temperature that it produced thermal breakdown products (so-called dry puff conditions), but no user would ever be able to use it this way – the vapour would be too acrid. They went on to calculate human cancer risk from these unrealistic machine measurements and presented the data in way that was bound to mislead, which it duly did and created a world-wide media storm. This was irresponsible science, careless publishing, and credulous journalism adversely changing the perceptions of the relative risks of smoking and vaping in a way that will cause harm. The paper should be retracted in its entirety".
And on and on and on. 'Experts,' media, spouting crap, anything to demonise this perceived threat - and not necessarily a threat to the vaping consumer. Lipoid Pneumonia, Tuberculosis, cancer, gateway,However, thank goodness, there are real experts out there. [Note, no inverted commas].
And now we come to the present day, yesterday in fact. Yesterday I read an article by Sofia Carlsson, Associate Professor, Institute of Environmental Medicine, Karolinska Institute, and Cecilia Magnusson, Professor, Department of Public Health Sciences, Karolinska Institute, here. [You may have to use translate]
They discuss a paper purporting to show a connection between heavy snus use and diabetes type 2. Before saying anything about this, in the above [linked] article they stress, and stress it more than once, that we should not jump to conclusions as there may be confounding factors - how very refreshing...
They also state as a fact: "Smoking is an established risk factor for diabetes, and a new problem in previous studies has been to separate snuff effects from smoking as inter use is common."
This comment started warning bells ringing. So I Googled (five minutes' worth) and the very first thing I came up with was... (page 250)
"Then there are quirky findings. In the Sweden study, researchers also looked at the risks associated with using "snus."... In this study, and in contrast to smoking cigarettes, the use of this nicotine containing product did not significantly increase the risk of diabetes."
Oh aye! But it is the next paragraph I find really interesting.
"The Hopkins' study also had an unexpected finding. Although cigarette smoking was clearly linked to type 2 diabetes, stopping smoking led to higher short term risk. highest in the first three years after cessation with a hazard ratio of 1.9. The last finding is a head scratcher. A report from the University of Oxford, England, involved 1,919 patients followed over 6 years. Of these subjects, 1,216 were initially free of retinopathy
Hang on a second, what on earth is retinopathy? I am not an expert you see. Right, Google: 'Diabetic retinopathy is a complication of diabetes, caused by high blood sugar levels damaging the back of the eye'
and 22% developed the pathology over the next 6 years. Of the 703 persons with retinopathy at the onset of the study, 29% progressed with 2 scale steps or more... Not smoking had an unfavourable effect on the development or progression of retinopathy.
A head scratcher right enough.
Sofia Carlsson, and Cecilia Magnusson, rightly emphasise that there may be many confounding factors but also state that, they, "have also, insofar as possible, taken into account other risk factors for type 2 diabetes such as overweight, physical inactivity, heredity, alcohol consumption, and education level." Did they? I do not have access to the research and even if I did, I doubt that I would understand much of it. It just seems to me to be an echo of previous, dubious e-cigarette studies. It just seems to me that not enough attention has been paid to the lifestyles of the participants... For example, is it the case that, like so many heavy smokers, heavy snus users are concentrated within specific society groupings, that they tend to be less active: that their diets are poorer; they belong to a particular ethnic group. (Some racial, ethnic groups continue smoking cigarettes at higher rates) Whatever...
It seems dubious to me that just because diabetes is higher in heavy snus users that it is the snus which is the cause? The researchers welcome any discussion - so do I.
But why do so many researchers publish materials that that are so far from the truth? What can it be that motivates them to go down this road? Michael Siegel, Professor in the Department of Community Health Sciences at Boston University School of Public Health gives us an insight into the world of Tobacco Control. He paints a picture of a world where individuals are indoctrinated and controlled. A world which will broke no contradiction; suffer any criticism.
He says, in an article, containing a great deal more...
"...if I conduct a study and it fails to show a significant relationship between second hand smoke and chronic disease, then all of the sudden, I have automatically become an illegitimate scientist."
"If it fails to show." Is this why so many 'studies' risk ridicule; a combination of induced blindness and fear?
"I was able to overcome my "brainwashing," but it took a lot of courage to do so, and a lot of risk to my career. I paid a heavy price for breaking out of the mould into which I had been cast. It shattered my career in tobacco control. But at least it didn't shatter me, and the person who I really am."
How many experts show this kind of courage, and the answer, surprisingly, is quite a few... these are the experts, the genuine ones, and their number is growing.
The edifice which is Tobacco Control is crumbling. Soon it will be gone.
New Nicotine Alliance would like to offer our thanks to Robert Innes for this guest blog entry. He can be reached on Twitter at @brainyfurball
The EU consultation on excise duties applied to manufactured tobacco ends on 16th February and includes proposals to tax reduced risk nicotine products. It’s vital that nicotine consumers respond to make their feelings known. If the EU permits taxation on reduced risk products the prices will go up and many people will be discouraged from switching. It’s simple and quick to respond to the consultation - it only takes around 15 minutes. Vapers in Power has done a useful guide to it, here. The Clive Bates/NNA briefing is here.
Here's a repost of NNA's "EU Tax policy - harmful to health - our briefing", in case you missed it the first time round:
The EU Commission is currently consulting on a revision to the Tobacco Excise Directive, which could see reduced risk products such as e-cigarettes being included. Our associate Clive Bates has written an in depth briefing together with NNA which details why this is a very bad idea. The full briefing can be read here. The consultation can be found here.
There is no case on principled or practical grounds to apply excise duties to vaping products and other products that offer a much safer alternative to smoking. The value to health and wellbeing associated with switching from smoking to vaping will exceed any benefits arising from revenue collection.
Just as it was with the Tobacco Products Directive, the inclusion of products which do not contain tobacco in the Tobacco Excise Directive is unhelpful and risks creating confusion in the minds of consumers.
If vapour and other reduced risk products are to be included in the directive then our view is as follows:
Excise policies on reduced risk products can have a significant negative impact for human health and is inconsistent with EU requirements to make policy with a high level of health protection.
The EU principle of 'non-discrimination' requires that products with very different characteristics are not treated in the same way - the vast difference in health risks means that reduced risk products must have zero or very low taxation relative to smoked tobacco products.
There is an opportunity to create a regime which will incentivise use of the safer products.
The risk is that poor policy will reduce this incentive, and so protect the market for smoked tobacco products.
Excise duty is a 'sin tax' and switching to low risk products is a virtue to be encouraged, not a sin to be taxed.
Our recommendations for low risk non combustible products are as follows:
If they are included in the directive then a zero rate duty must be allowed.
There should be a maximum rate set which reflects the very substantial difference in risk compared to smoked tobacco.
We urge the European Commission, European Council and member state tax authorities to take great care in striking the balance between public health, revenue raising and administrative costs. The institutions involved should conduct thorough impact assessments, take a hard look at the risks of causing harm to health and then think again about imposing excise duties on products that are already helping millions of Europeans to improve their health and wellbeing and have the potential to help millions more.
On the day that NNA was in the High Court asking for permission to join the effort to overturn the ludicrous ban on snus, and Hertfordshire County Council were holding their very successful 'e-cigarette masterclass', at which delegates learned about vaping, and sensible vaping policy, Public Health Wales issued their new position on e-cigarettes. http://www.wales.nhs.uk/sitesplus/888/news/43873
It is difficult to imagine the machinations that must have gone on within PHW whilst coming to this position. Seemingly realising that a failure to admit that e-cigarettes are very much safer than smoking tobacco cigarettes is now akin to being an anti-vaxxer, they grudgingly advise that anyone who is unwilling or unable to stop smoking should switch to vaping instead. Quite why anyone would want to do so given the rest of the PHW statement is anyone's guess.
Cherry picking from the US Surgeon General report, and of course the World Health Organisation, we are told that:
There are no benefits to children or young people using e-cigarettes.
No one wants to see young people initiate nicotine use via any method, but for those who have or will take up smoking there are definite benefits.
'Confectionary-like' (sic) flavours of e-liquid should not be permitted, in order to reduce the appeal of ENDS to children and young people.
How many times do we have to point out that the majority of adults prefer candy and fruit flavours. Certainly these flavours should be marketed responsibly, but in light of the fact that there is no evidence that 'confectionary-like' flavours, or indeed any other flavours, cause young people to take up regular vaping, all that this policy would achieve is to make e-cigarettes less appealing to those adult smokers who, as PHW admits, would benefit from switching.
Until a more definitive risk assessment can be completed, voluntary restrictions on the use of ENDS in enclosed public spaces should continue.
No doubt PHW would have preferred to push for legislative bans, but given what happened last time they tried, they settle for telling Welsh businesses to do that job for them. Contrary to PHW's carefully selected 'evidence' on this issue, there is no evidence at all of a risk of harm to bystanders, or that vaping renormalises smoking.
Additional 'factoids' in the statement include:
"Use of e-cigs may reduce the likelihood of smokers quitting by displacing scientifically proven methods to help people quit."
"The use of ENDS will act as a gateway to tobacco use."
Needless to say there is no evidence to suggest that either of the above concerns are happening in the real world.
In summary, whilst PHW's assertion that for a smoker, switching to e-cigarettes will significantly reduce the risk of harm to health is welcome, this statement is completely outweighed by the very negative comments which follow. We can all guess what this information will look like:
"Public Health Wales will include information on ENDS alongside other aids to stopping smoking in all information materials and in Stop Smoking Wales support services. Information on all products will be presented to support smokers in making an informed choice about the best way to quit for them."
NNA associates attended a debate at London South Bank University on Tuesday evening entitled “A way forward – How e-cigarettes could and should affect public health” which, sadly, only resulted in conveying an entirely misleading message to the approximately 50 people in the auditorium along with many more who logged on to watch a live stream of the event on Facebook.
Unfortunately, most of the panel did public health a significant disservice by repeating almost all the ill-informed canards that their more enlightened colleagues have sought to dispel over the past few years about vaping.
For example, Faculty of Public Health board member Patrick Saunders began the evening stating confidently that there is evidence that e-cigarettes inhibit smoking cessation rather than help smokers switch to vaping – which is quite wrong - and followed up later by dramatically declaring e-cigarettes to be “designed to mimic smoking, are intended to mimic smoking” with no recognition that this might be a positive attraction for smokers wishing to quit. He also said that it was “encouraging to see most places ban smoking and vaping” without a care that Public Health England has rightly identified the public health advantages of vaping being permitted where smoking isn’t.
Professor Andy Parrott of Swansea University – when not advocating for public information films showing tumours and gore to be shown on CBeebies – added that “nicotine is the ideal training drug for addiction” leading to addiction to harder drugs; an idea entirely unsupported by any science, and said that he would recommend nicotine patches over e-cigarettes despite research proving the latter to be more effective.
Dr Helen Walters of the National Institute of Health Research, while mildly supportive of vaping, also appeared to be singing from the vape-sceptic hymn sheet by declaring that she was happy that evidence shows e-cigarettes not to be a gateway into smoking for children in the UK, but that it is a different situation in the US despite youth smoking rates plummeting across the Atlantic too.
It was quite clear that some panellists possessed scant knowledge of the research conducted on e-cigarette health effects and usage, while in amongst all this was Professor Peter Hajek attempting to share the real evidence but being largely ignored in favour of falsehoods spread by other ‘experts’ on the panel. If that was disappointing, it only deteriorated further once discussion was opened to the floor. One by one all the lazy myths about vaping came tumbling out, and there was precious little pushback from the panel to correct them.
The oft-repeated misconception was advanced that a former smoker used his vaping equipment far more often – thereby implying he was self-administering more harm - without anyone pointing out that e-cigarette nicotine delivery is more dilute and tempered compared with smoking so this is a normal occurrence. Public health officers were forthright in condemning e-cigarettes for “substituting one addiction for another” without being educated that nicotine is on a par with caffeine, while another public health professional asserted boldly that “nicotine doesn’t break any kind of habit”, which any e-cigarette user will be able to tell you is not the case.
As for the idea that people might actually enjoy using nicotine and that the safer it is delivered, the better, the wholly clinical approach to the subject matter meant that the very premise was not up for discussion. Although it is encouraging that a London university decided to schedule an event on vaping, it was not so much a debate as a kangaroo court whereby vapers were offered no real defence.
If these misconceptions are to be addressed, and assuming the public health community truly wants to properly understand the attraction of vaping and its potential for public health, it is essential that this kind of event includes people who can do exactly that. Not, as was the case on Tuesday, in the audience with the chance of a minute or two at most to counter the untruths, but on the panel with a microphone given equal prominence and respect. The NNA can boast dozens of citizen experts who are qualified by their experience to talk about the subject and who are far more knowledgeable than many of those on display at South Bank University.
If those entrusted with advising parliamentarians and policy-makers wish to make a positive contribution to public health in the UK, they simply cannot preach ignorantly from their privileged pulpit like this. On Tuesday, they sent a cohort of local authority public health officers and interested students out into the chilly London air with negative, incorrect and evidence-free opinions about vaping to share with their friends and colleagues. They had been informed by ‘experts’, after all.
The way this event was structured may have been well-meaning, but in practice it has caused harm by effectively disparaging a technology which carries huge beneficial potential for population health in the UK and beyond. Health debates like this must include consumer advocates to offer a differing – and informed – view in the future; to not do so is nothing short of ideological public health vandalism.
Andrew Hall may not be the most competent vaper on the planet, but he’s not solely to blame.
You may have seen the media stories today about the Idaho man whose e-cigarette exploded. It seems he was using a hybrid mod. The vast majority of e-cig users use regulated mods containing inbuilt electronic safety features which mechanical and hybrid mods do not have. No reputable vendor will sell a hybrid or mechanical mod to a non advanced user.
NNA trustee David Dorn explains more below:
If you are not aware that Facebook managed to bring the notion of battery and mech mod safety to the fore on January 16th 2017, then you’ve missed a watershed moment in vaping circles.
Let’s precis: Before the Deeming rules came into force in the USA, Andrew, apparently, was using a mechanical mod (that is to say a battery unit with no electronics to protect or regulate the power of the device). It seems to have been a hybrid mod. A hybrid has no 510 connector as we all know it, but simply has a thread to attach a dripper or tank, and relies on the centre post of the dripper (we’ll say) contacting the positive terminal of the battery cell when it’s pushed up by the bottom button. Such a device is inherently unsafe unless a number of criteria are met: 1: The tank or dripper - the atomising device - MUST have a protruding centre contact. 2: The contact cannot be sprung or articulated in any way that would allow the battery’s positive terminal to make contact with the threaded section 3: No matter how far the atomising device is screwed into the hybrid connector, it must never make contact with the positive terminal of the battery unless the button has been pressed 4: Each and every battery used in the device can have no splits, tears or cracks And that’s just the tube itself. If any one of those criteria are not met, there is a very much increased chance of a short circuit scenario occurring, and when a battery cell is short circuited, then thermal runaway is highly likely. As I said, that’s just the battery tube.
Resistance is not futile The next weak link is the coil itself. Generally speaking, in a regulated device, the resistance of the coil(s) is matterless. As long as said resistance falls into the range that the mod can handle, it will deliver regulated power at the user’s chosen level without any issues. If the resistance of the atomiser setup is too low, the electrnics therein will prevent any current from flowing. Not so with a mech or hybrid. There is no intelligence. Reports suggest that Andrew was using a 0.06ohm coil - and although this is far from confirmed, such resistances in coils are not unusual. And that would be fine if, and only if, the battery cell in the device was capable of handling the currents generated when the setup is powered up. In this case, Andrew was expecting an 18650 battery to produce something over 50 Amps (bordering on 200 watts). Without wishing to alarm too many people (just the right ones) there is no 18650 on the market which will produce that much power safely and reliably. Many will do exactly what his did and vent/blow up. In the scenario where a hybrid mod is used and the connector on the atomising device is either flush or recessed, a dead short will occur. In this case, the resistance of the coil is matterless - there is no resistance to the current, and thermal runaway can be almost instant, with little or no notice. It looks awfully likely that that is what happened in this case.
Avoidable? Yes - this kind of thing is totally avoidable. The generality of users, as with all generally available stuff, ought not to need to know Ohm’s law in order to use an ecig safely. That it is not only possible, but also very easy to buy a battery unit which is fully protected, can produce high power and massive clouds, and will not allow you to put yourself in danger by mismatching bits of the setup. Not only that, but such mods will very often be considerably cheaper than boutique hybrids and mechs - it’s not difficult to choose a battery unit that will produce exactly what you need in terms of safely generated power - there are many on the market.
So where next? This is the controversial bit. Look, there are folks out there who are unwittingly lead into purchasing hybrids and mechs. They are, frankly, sexy, “scene”, used by the top echelon of trick vapers and there is a level of kudos applied to users of the most sought-after units. I get that. But they should NOT be the default “next step” in a vaper’s journey. Indeed, were it up to me, I’d be asking vendors not to display them or advertise them. The vast bulk of mainstream vapers are not competent to use them safely. (That’s not to say that those vapers are in any way second class or deficient. For instance, I am not competent to service a motorcycle - it’s not because I’m thick, it’s because I don’t have either the necessary skills or training to do so safely - and when it comes to hybrids, particularly, mistakes are all too easy to make). So, my plea to vape shops” 1: don’t display hybrids and mechs - those vapers who understand them and know them will know you have them. Let them ask. 2: should someone wander into your shop with an ego or an iStick and ask for a mech or hybrid, ask the right questions to determine whether they know what they’re doing. The first one is “WHY?” the answer to that tells you everything you need to know. 3: If a customer constantly comes in for you to re-coil a mech or hybrid device, do your very best to take their setup in part ex for something regulated and safe. Please.
Think about it.
This unfortunate happening has resulted in massive publicity, has certainly resulted in people dumping their ecigs and going back to smoking, and that is, in fact, a net lowering of your customer base.
We have to do everything we can to prevent such things happening again. If we don’t “they” will, and regulations no-one wants will ensue.
Researchers based in North Carolina have discovered that if you lie to smokers about the amount of harmful chemicals in e-cigarettes compared to traditional cigarettes you will put them off using the products. In a study entitled 'How hearing about harmful chemicals affects smokers' interest in dual use of cigarettes and e-cigarettes', Pepper et al present smokers with four scenarios and then analyse their attitude towards dual use of the products with smoking. The four scenarios were:
That cigarettes and e-cigarettes had the same amount of harmful chemicals
That cigarettes contained 10x more harmful chemicals than e-cigarettes
That cigarettes contained 100x more harmful chemicals than e-cigarettes
That cigarettes contained harmful chemicals and e-cigarettes contained none
Unsurprisingly, in the scenarios where e-cigarettes contained less or no harmful chemicals participants indicated that they would be more likely to initiate or increase dual use of cigarettes and e-cigarettes.
What isn't immediately obvious from the publicly available abstract, but is noted in the limitations section of the full paper hidden behind a paywall, is the fact that the study concentrated on those smokers who said they would start or increase their use of e-cigarettes without stopping smoking. So smokers who indicated that they would completely switch to the safer product were excluded.
Astonishingly, the authors concluded that this apparent encouragement of dual use created by giving smokers accurate information on the relative numbers of harmful chemicals in the products would lead to a harmful continuation of smoking, and that therefore e-cigarettes "may not be able to be approved as a modified risk tobacco product on the basis of reduced chemical exposure alone because the public views information about lower chemical amounts as inherently related to reduced health harms". Paracelsus must be turning in his grave. The underlying suggestion in the conclusion to this study is that the FDA should consider hiding the the fact that e-cigarettes contain vastly reduced numbers and amounts of harmful chemicals when compared to smoking combustible cigarettes.
It is deeply concerning, but unfortunately not surprising to those of us who regularly read the bilge coming out of certain parts of the world, that researchers should feel comfortable suggesting that lying to smokers about the relative risk of products would be a viable public health policy. The obvious consequence of such a policy is that some people who might otherwise have switched to a safer alternative will continue to smoke. It is unfortunate that these researchers appear to have completely ignored them. Whatever happened to ethics?
2016 has been a lively year for tobacco harm reduction and, as you’d expect, the NNA has been extremely busy. This post can’t detail all that we’ve been involved with but we hope here to give you a flavour of our year. There is still much work to do going into 2017 and we are very grateful to all of you who have helped us to get this far: whether by signing up as a supporter, by sharing our posts, giving us advice, donating money or a stand at an expo. We simply cannot do what we do without your help. Thank you. No matter what skill set you have you can be an asset to the NNA, so please drop us a line if you can help.
Last minute victory in Wales
The Public Health (Wales) bill sought to ban the use of e-cigarettes in public spaces so we were delighted when the bill was defeated in March. The NNA, along with other groups and many scientists, had opposed the measure since it was first proposed two years previously. The sinking of the bill was a victory for NNA trustee Simon Thurlow and colleagues’ hard work - and a victory for common sense.
NNA Scotland is, quite possibly, too busy. Fortunately NNA trustee Andy Morrison’s load should be a lot lighter in 2017 because he’s now been joined by new associates Jamie Hollywood, Lorna Strachan and Robert Innes.
Andy was involved in organising the very successful Glasgow School of Vape 3. The day built on the previous Glasgow School of Vape events, bringing smokers,vapers and vendors together so that they could learn from one another. Other invitees this time included people from public health and stop smoking services and researchers from Glasgow and Stirling universities.
The Roy Castle Lung Cancer Foundation study: a study designed to identify the role that e-cigarettes can play in helping people who continue to smoke after a lung cancer diagnosis. Andy and a small group of e-cigarette users are assisting the researchers with home visits to see patients and offer ongoing support through the study. Andy is now assisting with a cardiovascular study too, organised along much the same lines as the Roy Castle one.
Scottish Parliament Event at Holyrood. A discussion about e-cigarettes and individual and public health. This was organised by the NNA and chaired by trustee Gerry Stimson. The panel featured Sheila Duffy (ASH Scotland), Dr Christopher Russell (Centre for Drug Misuse Research, Glasgow), Professor Linda Bauld (Stirling University),NNA patron Steve Christie, Mike MacKenzie (MSP), NNA trustee Paddy Costall and an audience of public health, vapers and vendors. The event was very lively and informative.
Ensuring that vapers have a voice in the ongoing debate: Andy is in regular communication with Sheila Duffy (ASH Scotland) and NHS Glasgow and Clyde and has a positive ongoing dialogue with MSPs and other representatives too. Andy also assists university students and academics on various projects enhancing their understanding of e-cigs and the politics surrounding their use.
A Billion Lives: Andy organised and presented at the UK premier of A Billion Lives in Glasgow, in October. This was well attended by press, public health and vapers.
The Department of Health and the MHRA
NNA trustees have attended various meetings with the Department of Health and the MHRA this year. Meetings centred on the Tobacco and Related Products Regulations and the WHO FCTC COP7. We followed up the Department of Health round table meeting in March with a written submission on the unintended consequences of vaping regulation, written by NNA associate Clive Bates (Counterfactual Consulting). NNA trustees have also been very engaged with local stop smoking services, in various parts of the country.
Consultations and briefings
January saw the publication of the excellent NCSCT briefing on electronic cigarettes for stop smoking services, which had been reviewed by NNA trustees Sarah Jakes and Lorien Jollye. The NCSCT has also asked the NNA to advise on and help disseminate some short videos on vaping, produced by the NCSCT for Public Health England. The first video is due to be released in January 2017 so please look out for it.
March: Sarah Jakes was appointed member of the NICE committee on guidance to stop smoking services.
September: The NNA responded to New Zealand's Ministry of Health on policy options for the regulation of e-cigarettes.
NNA trustees are advising on various studies, topics include: health professionals and their attitudes to e-cigs and NRT with cancer sufferers, the real world experiences of using e-cigs to avoid going back to smoking, the effects of e-cigs on people with stage 4 lung cancer and those suffering from COPD, effects of e-cigarettes on cardiovascular patients and a dentistry study.
All-Party Parliamentary group for E-Cigarettes
The NNA continued to be involved with the APPG this year.
Gerry Stimson and Lorien Jollye both spoke at the January meeting. Lorien focussed on the TRPR’s impact on smokers and new vapers and called for public health bodies to work together to mitigate the effects. In his presentation Gerry emphatically stated that all intervention, the TRPR included, should be judged against its contribution towards stopping smoking. Another of Gerry's key points was that “vapers and vape shops are the new front line in smoking cessation”.
The E-Cigarette Summit, November Andy Morrison and Sarah Jakes attended. Sarah was on the panel which discussed Communicating Research & Evidence.
The NNA was very fortunate to have been represented at the major events this year. It was really good to meet so many of our friends and supporters at them. The Vape Jam UK organisers gave the NNA and Vapers in Power a stand and also very kindly donated the proceeds of their raffle to us. NNA trustee Dave Dorn gave a rousing presentation, you can watch it here
Andy and Jamie attended Vape Collective,. They were delighted to get so many supporter sign ups and enjoyed sharing the marquee with ViP.
Vapefest: Andy and Jamie represented the NNA, sharing a tent with ViP again, and had a good time meeting up with old faces - and lots of new ones too.
The Vaper Expo organisers gave us a very generous donation too, money which we will put to very good use.
Thanks to a friend and supporter of NNA, Chinese e-cigarette manufacturer Innokin heard about the NNA’s work with stop smoking services and wanted to help. We do not take donations from anyone in the nicotine industries, so the best way for Innokin to help would be to help stop smoking services help smokers to stop smoking. This though is not as simple as it should be, because currently there are no medicinally licensed ecigs on the market which stop smoking services could prescribe, and it's likely that any that do gain medicinal authority will be bland cousins compared to those on the consumer market.
We were sorry that Alan Beard felt it was time to step down as Trustee. We were very grateful for the help he had provided to NNA.
We are delighted that Dr Heather Morgan has joined us as our newest trustee and also very pleased to announce that Andrew RT Davies, the leader of the Welsh Conservatives, will be joining the NNA as patron.
We’ve recently appointed a part time administrator, to take the pressure off our overworked trustees. This should lead us into an even busier year in 2017.
It’s wonderful that our list of supporters has doubled this year - but we always need more. It costs nothing to sign up as a NNA supporter and the more supporters we have the more influential we can be. You can sign up here and please consider asking your family and friends to sign up too.
A further shift will unlock greater potential On Tuesday during questions to the Under-Secretary of State for Health in Westminster, Nicola Blackwood replied to a query from Conservative MP Adam Afriyie about the use of e-cigarettes and, specifically, the negative outcomes that will undoubtedly arise from implementation of the EU TPD. The Government are very clear that vaping is significantly less harmful than continuing to smoke. Under the current regulatory regime, huge numbers of smokers are successfully using these innovative products as an effective quitting tool. We have already committed to reviewing the TPD and we will fully explore the opportunities that Brexit may provide, but until exit negotiations are concluded we remain a full member of the EU. We note and very much welcome Ms Blackwood confirming that there will be a review of the terms of the TPD. They were hastily-drafted and implemented largely from a position of ignorance by MEPs and their advisers in 2014, and we still maintain that many of the requirements are not only unnecessary but also harmful. In the intervening period since the TPD was formulated there has been a shift in perception – backed by a solid evidence base - of the benefits of vaping and tobacco harm reduction in general, so it is of great interest that a government minister is considering the TPD’s efficacy and legitimacy in a post-Brexit United Kingdom. However, there is another small but significant shift in policy required if the full public health potential of tobacco harm reduction methods is to be realised, and it is only the UK government which can affect the change required to facilitate this. It is still officially the government position that e-cigarettes, particularly, should only be used as a smoking cessation aid and not as a recreational product. Indeed, the Department of Health’s representative in the House of Lords, Lord Prior of Brampton, responded on Tuesday to his shadow Lord Hunt of Kings Heath’s support of e-cigarettes by saying that “better than vaping is not to vape or smoke cigarettes or anything else at all”. This is to fundamentally misunderstand the positive public health role that harm reduction can play. Lord Hunt – on the other hand – understands the debate very well in his position as President of the Royal Society of Public Health, one of many UK health organisations to enthusiastically embrace vaping. The Royal College of Physicians has argued that e-cigarettes should be “promoted as widely as possible”, while the government’s pre-eminent public health advisers Public Health England recognise the advantages of vaping and have consulted with consumer groups such as the NNA on the matter. Guidance from the National Centre for Smoking Cessation and Training has also rightly warned against being alarmed about recreational vaping, stating that “we are not a ‘stop nicotine service’ and if we think getting people off their e-cigarette is a good use of our time, we are ignoring a far more important opportunity to help people quit and to stay off cigarettes.”. With all this wise counsel from respected advisers moving in the same direction of travel, it is arguably time for the government to revisit and re-consider its stubborn policy towards recreational use of nicotine. As the NNA has consistently advocated, a vast number of people derive great pleasure from nicotine just as millions enjoy coffee containing caffeine – both judged to be on the same toxicity level by experts – yet we do not hear of government campaigns to wean the public, or even MPs themselves, off coffee. Smokers are not ill and do not require a medical intervention; in fact, for many the very idea is anathema and would deter them from switching to a less harmful alternative. The huge and swift success of vaping in the UK has occurred not because it is viewed exclusively as a smoking cessation device – quite the opposite – instead the success is attributable to vaping being an enjoyable, healthier pastime free from the pressure of real or imagined state coercion. If full nicotine cessation then ensues then so be it, however that should not be the sole consideration. Nicola Blackwood and Lord Prior have been presented with a largely cost-neutral free market solution to their goal of reducing smoker prevalence, they should seize it by embracing recreational vaping, like many of their most respected public health advisers have. In doing so, and eschewing the siren voices of those who value moral judgements over concrete health benefits by calling for regulations, restrictions and bans, they can unlock the full advantageous potential of e-cigarettes and tobacco harm reduction.
The report from the US Surgeon General on e-cigarette use among youth and young adults is just one more example (as if any more were needed) of the lengths to which the prohibitionist faction of tobacco control will go in order to promote its evidence-free ideological agenda. The report cherry picks 'scientific' claims of risk to young people, mainly from studies or analysis which have long since been debunked by experts in the field, and almost completely ignores the large body of science which details the benefits of e-cigarettes to smokers of all ages as either a cessation or harm reduction strategy. The fact that smoking prevalence among young people has declined dramatically concurrent with increased availability of e-cigarettes also seems to have escaped the Surgeon General's attention completely. This report and the policy recommendations contained within leave us in no doubt that regulators in the US care nothing for the lives of current smokers, or of those who will take up the habit in the future. It compounds the misperception that vaping is as dangerous as smoking and it will serve as protection for the incumbent nicotine delivery method, tobacco cigarettes. Well done America. For more detailed analysis of the report please read Clive Bates post here: Bad science, poor insights and likely to do harm - rapid reaction to the Surgeon General's terrible e-cigarette report
Yesterday I spoke at the first meeting of the All Party Parliamentary Group on E-Cigarettes that has been held since trade body UKVIA took over the secretariat. The meeting was in two parts, the first part being an overview of the public health challenges and the second being "industry views" - I found myself rather incongruously in the second part.
Professor Kevin Fenton led off the first part by detailing the work undertaken to date by Public Health England in this area and outlining the challenges we still face. These included public perception of relative risk and the appalling manner in which the media approaches the subject. Professor Peter Hajek then explained the role that researchers have played in this, and detailed some of the methods employed in order to portray what are often trivial or irrelevant risks as important indicators of harm. After a brief foray into the role of UKVIA and how their involvement with the APPG may relate to article 5.3 of the FCTC, George Butterworth then described Cancer Research UK's involvement in research, and in particular their role in analysing and, if appropriate, debunking poor, or poorly reported studies.
After a couple of questions the second part began with Charlie Hamshaw Thomas (UKVIA and Nicopure) praising the UK stance on tobacco harm reduction and also how far industry had come in delivering new and ever better products. Ian Green (IBVTA) then spoke about the challenges which 'Italian style' enforcement would pose to an industry which had spent considerable sums on compliance. A representative from Trading Standards in the audience was asked how they intend to approach the issue, and he replied by saying that their response would be proportionate given the other issues which they are expected to deal with, and would likely be complaint-led in practice.
My turn came to offer the consumer view and I presented the challenges which consumers face under the new regulations and also due to the very poor public perception of vaping. Points raised included nicotine concentration limits, advertising restrictions, usage bans, and the activities of prohibitionist groups such as the BMA and the WHO.
Finally, Andrew Allison of The Freedom Association was invited to speak briefly about the report they compiled which revealed the atrocious state of local authority vaping policies. Kevin Fenton responded by explaining that PHE are working with some authorities on changing this, and will continue to try to improve the situation.
I'm told that 9 parliamentarians attended the meeting, either in person or via their researchers. Some interesting and pertinent questions were asked although time was very limited as we only had an hour. Hopefully future meetings can focus in on the individual challenges identified so that they can be discussed in more detail.
Transparency was on the agenda at COP7, apparently there were concerns after COP6, but (almost) unbelievably, what they achieved was to make it less transparent than ever before.
Prior to COP7 I asked the UK department of health what the problem was with allowing the media and the public, including the tobacco companies, to observe (not participate) and report on the negotiations that go on there. The answer was that the tobacco companies would target and intimidate those delegations with whom they disagree, and go on to interfere in tobacco control policy in those countries. The public and media had to be similarly excluded because the tobacco companies would infiltrate them, or go disguised as them. Paranoid stuff.
I don't think it's a secret that the tobacco industry had numerous representatives in Delhi, as did other independent interested parties such as Asian vaper groups, and even experts on tobacco harm reduction who were there to try to correct the appalling claims made in the WHO report on e-cigarettes. On the first day of COP all of these people were excluded, together with the scant media representation.
The result of this decision was that all independent reporting of the machinations of COP was blocked, but more importantly, so was scrutiny of the actions of the delegates involved. This gave them free rein to attempt to bring in draconian restrictions on harm reduced products with no fear of being challenged by anyone outside of the hallowed halls of WHO.
Well it would have, if it weren't for the numerous leaks that emanated from the process and filtered through to the excluded groups milling around outside.
FCTC is a treaty which the signatories agree to pass into national law. Those present at COP meetings are deciding law in 180 countries. They are deciding the fate of millions of people like me, who smoke or vape and they're doing it on our taxes. And yet the only route of communication we have with the process is via a confusing myriad of snippets occasionally leaked. The idea that the policy positions of the numerous party delegations should be kept secret for fear of intimidation is absurd and undemocratic. These are national government positions for heavens sake. As I write this I still don't know what the official decision on vaping actually is, although rumour has it that the UK position of blocking any new lunacy has prevailed. Who knows. The situation is beyond disgusting and cannot be allowed to carry on.
COP8 will be held in Geneva in 2018, which is a comparatively short journey for the millions of vapers in Europe. I hope to see a large number of them there. If they will not open the doors to us voluntarily we will just have to do whatever we can to force them. Bring it on.
Along with Adjunct Professor of Law at the University of Ottawa, David Sweanor, NNA associate Clive Bates recently submitted a response to the New Zealand Ministry of Health review into legalising e-cigarettes.
As is customary, Clive and David’s work is exemplary and has been featured online at New Zealand news source Stuff in an article entitled “International anti-smoking campaigners' ten messages on e-cigarettes”. It is a concise guide to the many harm reduction benefits of e-cigarette use - and conversely the dangers of over-regulation - which we can highly recommend all interested parties read.
However, one of their observations is particularly well-drawn and will resonate with many vaping consumers. On the subject of bans on e-cigarette use, Clive and David had this to say:
"It is quite possible that banning vaping in public places or severely restricting it would have adverse effects on health."
Today the Chartered Institute of Environmental Health has called for a voluntary ban on smoking everywhere and anywhere that children play or learn. On the face of it that would seem like sensible advice - except it wouldn't be advice, it would be a command, albeit not one that is currently enforceable.
The Framework Convention on Tobacco Control is the World Health Organisation’s masterplan to eliminate tobacco use. Its main activity is the two-yearly Conference of Parties, and the next one – COP 7 – will be taking place in India this November. Preparation for the conference is now in full swing, and various documents have now been released. This includes the WHO’s latest report on vaping.
Yesterday, NNA trustee Lorien Jollye took part in a half day panel debate at the Royal Society of Medicine entitled “Regulation of Pleasure”.
It was an eclectic event which encompassed topics as diverse as illicit drug use and consumption of online pornography, and was attended by around 40 interested medical practitioners and students. Lorien’s contribution was to recount “My relationship with nicotine” and she received much interest from the attendees during the question and answer sessions.
Make no mistake about it, Action on Smoking and Health (ASH) are lobbying very hard to rally opposition against Lord Callanan's fatal motion, which, if it were passed, would kill the Statutory Instrument (SI) which transposes the TPD into UK law.
In the now (almost) immortal words of Professor Gerry Stimson, 'vapers and vape shops are the new front line in smoking cessation services'. Typically this is an informal process with vape shops doing their best to help their customers to understand the products and how to use them, and vapers talking to their smoking relatives, friends and colleagues about their transition from smoking to vaping. Any vaper will tell you that there is a lot of interest among smokers about the devices and techniques involved, but also simply in 'how you managed to do it' and 'what it was like'.
In his recent paper published in the journal 'Addiction' Robert West and colleagues tried to count the number of additional people who successfully quit smoking in 2014 and would not have done so if ecigs didn't exist.You can read the paper here. The conclusions drawn in this analysis have prompted a great deal of debate.
In a report covered by PGVG magazine it was revealed that in Belgium a drug administered to patients with pulmonary fibrosis in order to stabilise the condition will no longer be reimbursed* by INAMI (the Belgian statutory national medical insurance association) to those who have smoked in the last 6 months.
Accept & Close
This policy describes how and why New Nicotine Alliance (UK) uses your personal information, how we protect your privacy when doing so, and your rights and choices regarding this information. We promise to respect any of your personal information which is under our control and to keep it safe. We aim to be clear when we collect your information about what we will do with it.
This policy is effective from 25th May 2018
Data protection is a high priority for the management of the New Nicotine Alliance UK. Use of the New Nicotine Alliance UK website is possible without the user needing to input any personal data; however, if a data subject wants to use certain services on our website, the processing of their personal data could become necessary. If the processing of personal data is necessary and there is no statutory basis for such processing, we generally obtain consent from the data subject.
The processing of personal data, such as the name, address, e-mail address, or telephone number of a data subject will always be in line with the General Data Protection Regulation (GDPR), and in accordance with the country-specific data protection regulations applicable to the New Nicotine Alliance UK. By means of this data protection declaration, we would like to inform the general public of the nature, scope, and purpose of the personal data we collect, use and process. Furthermore, data subjects are informed, by means of this data protection declaration, of the rights to which they are entitled.
As the controller, the New Nicotine Alliance UK has implemented numerous technical and organisational measures to ensure the most complete protection of personal data processed through this website. However, Internet-based data transmissions may in principle have security gaps, so absolute protection may not be guaranteed. For this reason, every data subject is free to transfer personal data to us via alternative means, e.g. by telephone.
1. Definitions The data protection declaration of the New Nicotine Alliance UK is based on the terms used by the European legislator for the adoption of the General Data Protection Regulation (GDPR). Our data protection declaration should be legible and understandable for everyone we engage with. To ensure this, we would like to first explain the terminology used. In this data protection declaration, we use, inter alia, the following terms: a) Personal data Personal data means any information relating to an identified or identifiable natural person (“data subject”). An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person. b) Data subject Data subject is any identified or identifiable natural person, whose personal data is processed by the controller responsible for the processing. c) Processing Processing is any operation or set of operations which is performed on personal data or on sets of personal data, whether or not by automated means, such as collection, recording, organisation, structuring, storage, adaptation or alteration, retrieval, consultation, use, disclosure by transmission, dissemination or otherwise making available, alignment or combination, restriction, erasure or destruction. d) Restriction of processing Restriction of processing is the marking of stored personal data with the aim of limiting their processing in the future. e) Profiling Profiling means any form of automated processing of personal data consisting of the use of personal data to evaluate certain personal aspects relating to a natural person, in particular to analyse or predict aspects concerning that natural person's performance at work, economic situation, health, personal preferences, interests, reliability, behaviour, location or movements. f) Pseudonymisation Pseudonymisation is the processing of personal data in such a manner that the personal data can no longer be attributed to a specific data subject without the use of additional information, provided that such additional information is kept separately and is subject to technical and organisational measures to ensure that the personal data are not attributed to an identified or identifiable natural person. g) Controller or controller responsible for the processing Controller or controller responsible for the processing is the natural or legal person, public authority, agency or other body which, alone or jointly with others, determines the purposes and means of the processing of personal data; where the purposes and means of such processing are determined by Union or Member State law, the controller or the specific criteria for its nomination may be provided for by Union or Member State law. h) Processor Processor is a natural or legal person, public authority, agency or other body which processes personal data on behalf of the controller. i) Recipient Recipient is a natural or legal person, public authority, agency or another body, to which the personal data are disclosed, whether a third party or not. However, public authorities which may receive personal data in the framework of a particular inquiry in accordance with Union or Member State law shall not be regarded as recipients; the processing of those data by those public authorities shall be in compliance with the applicable data protection rules according to the purposes of the processing. j) Third party Third party is a natural or legal person, public authority, agency or body other than the data subject, controller, processor and persons who, under the direct authority of the controller or processor, are authorised to process personal data. k) Consent Consent of the data subject is any freely given, specific, informed and unambiguous indication of the data subject's wishes by which he or she, by a statement or by a clear affirmative action, signifies agreement to the processing of personal data relating to him or her. 2. Name and address of the controller Controller for the purposes of the General Data Protection Regulation (GDPR), other data protection laws applicable in Member states of the European Union and other provisions related to data protection is: New Nicotine Alliance UK 8 Northumberland Avenue WC2N 5BY London United Kingdom